Health Canada drug identification number

DIN 02536862 — THIOTEPA FOR INJECTION, BP 15 MG

THIOTEPA FOR INJECTION, BP is a powder for solution of Thiotepa marketed by HIKMA CANADA LIMITED. The full Thiotepa monograph covers indications, dosing, interactions and counselling for every strength and manufacturer.

DIN
02536862
Brand name
THIOTEPA FOR INJECTION, BP
Active ingredient
Thiotepa
Strength
15 MG
Dosage form
POWDER FOR SOLUTION
Route
INTRAVENOUS
Manufacturer
HIKMA CANADA LIMITED
Health Canada status
MARKETED
Drug class
Antineoplastic agent (alkylating agent)

Product data from the Health Canada Drug Product Database, synced . Verify the live status at Health Canada.

Other Thiotepa products

DINBrandStrengthFormManufacturerStatus
02462702 TEPADINA 100 MG POWDER FOR SOLUTION ADIENNE SA MARKETED
02462680 TEPADINA 15 MG POWDER FOR SOLUTION ADIENNE SA MARKETED
02523906 TEPADINA 400 MG POWDER FOR SOLUTION ADIENNE SA DORMANT
02526425 THIOTEPA FOR INJECTION USP 100 MG POWDER FOR SOLUTION STERIMAX INC MARKETED
02526417 THIOTEPA FOR INJECTION USP 15 MG POWDER FOR SOLUTION STERIMAX INC MARKETED
02536870 THIOTEPA FOR INJECTION, BP 100 MG POWDER FOR SOLUTION HIKMA CANADA LIMITED MARKETED

Rejoining the server...

Rejoin failed... trying again in seconds.

Failed to rejoin.
Please retry or reload the page.

The session has been paused by the server.

Failed to resume the session.
Please retry or reload the page.